Advertisement
Screener

ICU MEDICAL INC/DE (ICUI) Overview

ICU MEDICAL INC/DE (ICUI) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.76; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 1.20; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.14; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 1.43; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$109.68$123.26$138.52$155.68$174.96$196.622025-11-062026-11-06$77.03$98.23$125.27$159.76$203.74$259.832021-11-082026-11-06$77.03$102.74$137.04$182.80$243.83$325.242016-11-072026-11-06$21.38$36.84$63.51$109.47$188.69$325.242006-11-062026-11-06$2.95$7.57$19.37$49.60$127.02$325.241992-03-312026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$172.06
Previous close
$163.44
Change
$8.62
Change (%)
5.27%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

ICUI
+14.56%
S&P 500
(m)

1 year

ICUI
+39.64%
S&P 500
(m)

3 years

ICUI
+37.33%
S&P 500
(m)

5 years

ICUI
-30.71%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.76

-0.71-0.130.451.031.6131 Mar 2025: estimate (m); actual -0.6331 Mar 2025(m)30 Jun 2025: estimate (m); actual 1.4330 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.1430 Sept 2025(m)31 Mar 2026: estimate (m); actual 1.2031 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.7630 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.76(m)(m)
1 Jan 202631 Mar 2026(m)1.20(m)(m)
1 Jul 202530 Sept 2025(m)-0.14(m)(m)
1 Apr 202530 Jun 2025(m)1.43(m)(m)
1 Jan 202531 Mar 2025(m)-0.63(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 0.03

-4.91-2.450.002.464.9231 Dec 2021: estimate (m); actual 4.7431 Dec 2021(m)31 Dec 2022: estimate (m); actual -3.1131 Dec 2022(m)31 Dec 2023: estimate (m); actual -1.2331 Dec 2023(m)31 Dec 2024: estimate (m); actual -4.8331 Dec 2024(m)31 Dec 2025: estimate (m); actual 0.0331 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)0.03(m)(m)
1 Jan 202431 Dec 2024(m)-4.83(m)(m)
1 Jan 202331 Dec 2023(m)-1.23(m)(m)
1 Jan 202231 Dec 2022(m)-3.11(m)(m)
1 Jan 202131 Dec 2021(m)4.74(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 551.68M ■ Earnings 19.09M — Profit margin 3.46%

-70.01M-1.6%159.43M1.4%388.86M4.4%618.29M7.4%30 Jun 2025: revenue 548.87M; earnings 35.34M; profit margin 6.44%30 Jun 202530 Sept 2025: revenue 536.99M; earnings -3.40M; profit margin -0.63%30 Sept 202531 Mar 2026: revenue 530.23M; earnings 30.13M; profit margin 5.68%31 Mar 202630 Jun 2026: revenue 551.68M; earnings 19.09M; profit margin 3.46%30 Jun 2026

31 Dec 2025 ■ Revenue 2.23B ■ Earnings 0.00B — Profit margin 0.03%

-0.42B-5.9%0.62B-3.6%1.65B-1.3%2.68B1.0%31 Dec 2022: revenue 2.28B; earnings -0.07B; profit margin -3.26%31 Dec 202231 Dec 2023: revenue 2.26B; earnings -0.03B; profit margin -1.31%31 Dec 202331 Dec 2024: revenue 2.38B; earnings -0.12B; profit margin -4.94%31 Dec 202431 Dec 2025: revenue 2.23B; earnings 0.00B; profit margin 0.03%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$172.06(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$172.06High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning ICUI

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Index membership
(m)
Employees
13.00K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
262.49K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
1.53%*
Total return · month
-6.66%*
Total return · quarter
10.48%*
Total return · half year
31.60%*
Total return · year to date
14.56%*
Total return · 1 year
39.64%*
Total return · 3 years
37.33%*
Total return · 5 years
-30.71%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

ICU MEDICAL INC/DE Overview

View more →

(m)

(m)

SEC CIK
883984
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
951 CALLE AMANECER, SAN CLEMENTE, California, 92763-6212, United States
Fiscal year end
1231
Phone
949-366-2183

Similar stocks

Stock NameCountryMarket CapPE Ratio
Heartflow, Inc. (HTFL)United States$4.225B
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55